Ravit Geva

6 Weizmann Street, 6423906
Tel Aviv, TA 64239, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 96 publications

Adjuvant Chemotherapy ± Chemoradiotherapy for Adenocarcinoma of the Pancreatic Head: Results of the Radiotherapy Random Assignment of NRG Oncology/RTOG 0848.

Adjuvant Chemotherapy ± Chemoradiotherapy for Adenocarcinoma of the Pancreatic Head: Results of the Radiotherapy Random Assignment of NRG Oncology/RTOG 0848.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 15, 2026

Low Disease Burden in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Associated with Improved Outcomes: A Single Center Experience.

Low Disease Burden in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Associated with Improved Outcomes: A Single Center Experience.

Journal: The Israel Medical Association journal : IMAJ

Published: June 16, 2026

Evaluating Adenocarcinoma-Based Surgical Paradigms in Gastric Neuroendocrine Tumors: A Comparative Outcomes Analysis.

Evaluating Adenocarcinoma-Based Surgical Paradigms in Gastric Neuroendocrine Tumors: A Comparative Outcomes Analysis.

Journal: The American surgeon

Published: March 07, 2026

Prognostic Impact and Postoperative Management Following Poor Pathological Response to Perioperative FLOT in Resectable Gastric and GEJ Adenocarcinoma: A Systematic Review and Meta-Analysis.

Prognostic Impact and Postoperative Management Following Poor Pathological Response to Perioperative FLOT in Resectable Gastric and GEJ Adenocarcinoma: A Systematic Review and Meta-Analysis.

Journal: Journal of clinical medicine

Published: February 18, 2026

Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study.

Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study.

Journal: Cancer research communications

Published: January 14, 2026

Immunogenic effects of hyperthermia in an experimental model of peritoneal metastases of colorectal cancer enhance tumor susceptibility to immunotherapy.

Immunogenic effects of hyperthermia in an experimental model of peritoneal metastases of colorectal cancer enhance tumor susceptibility to immunotherapy.

Journal: Cancer treatment and research communications

Published: November 25, 2025

A Phase II Trial of an Extended-Release siRNA Implant Targeting KRASG12D/V in Locally Advanced Pancreatic Cancer.

A Phase II Trial of an Extended-Release siRNA Implant Targeting KRASG12D/V in Locally Advanced Pancreatic Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 23, 2025

Apoptotic Marker Analysis in Heated-Intraperitoneal Chemotherapy Effluent Fluid Is Associated With Prognosis in Patients With Peritoneal Metastases.

Apoptotic Marker Analysis in Heated-Intraperitoneal Chemotherapy Effluent Fluid Is Associated With Prognosis in Patients With Peritoneal Metastases.

Journal: Journal of surgical oncology

Published: August 07, 2025

Comparative Effects of THC and CBD on Chemotherapy-Induced Peripheral Neuropathy: Insights from a Large Real-World Self-Reported Dataset.

Comparative Effects of THC and CBD on Chemotherapy-Induced Peripheral Neuropathy: Insights from a Large Real-World Self-Reported Dataset.

Journal: Biomedicines

Published: July 02, 2025

The Empty Bladder is Preferred in Some Cases of Radiation Therapy for Rectal Cancer.

The Empty Bladder is Preferred in Some Cases of Radiation Therapy for Rectal Cancer.

Journal: Advances in radiation oncology

Published: June 24, 2025

First-in-human study of FAZ053, an anti-programmed death-ligand 1 (anti-PD-L1) monoclonal antibody, alone and in combination with spartalizumab (anti-PD-1), in patients with advanced malignancies.

First-in-human study of FAZ053, an anti-programmed death-ligand 1 (anti-PD-L1) monoclonal antibody, alone and in combination with spartalizumab (anti-PD-1), in patients with advanced malignancies.

Journal: ESMO open

Published: December 05, 2024

MRI is more accurate than FDG-PET in assessing complete response in rectal cancer patients after neoadjuvant therapy.

MRI is more accurate than FDG-PET in assessing complete response in rectal cancer patients after neoadjuvant therapy.

Journal: Langenbeck's archives of surgery

Published: September 18, 2024

Showing 1-12 of 96

Last Updated: 09/26/2026